BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

862 related articles for article (PubMed ID: 19059358)

  • 1. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future trends in the application of HPLC-MS to metabolite-identification studies.
    Castro-Perez JM
    Drug Discov Today; 2007 Mar; 12(5-6):249-56. PubMed ID: 17331890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles and applications of LC-MS in new drug discovery.
    Korfmacher WA
    Drug Discov Today; 2005 Oct; 10(20):1357-67. PubMed ID: 16253874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolite identification using fast gradient high performance liquid chromatography combined with tandem mass spectrometry.
    Hop CE; Tiller PR; Romanyshyn L
    Rapid Commun Mass Spectrom; 2002; 16(3):212-9. PubMed ID: 11803543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in applications of liquid chromatography-tandem mass spectrometry to the analysis of reactive drug metabolites.
    Ma S; Zhu M
    Chem Biol Interact; 2009 Apr; 179(1):25-37. PubMed ID: 18848531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of pharmacokinetic study samples by liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS).
    Mück W
    Pharmazie; 1999 Sep; 54(9):639-44. PubMed ID: 10522267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids.
    Plumb RS; Stumpf CL; Granger JH; Castro-Perez J; Haselden JN; Dear GJ
    Rapid Commun Mass Spectrom; 2003; 17(23):2632-8. PubMed ID: 14648901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-performance liquid chromatography coupled to linear ion trap mass spectrometry for the identification of drug metabolites in biological samples.
    Dear GJ; James AD; Sarda S
    Rapid Commun Mass Spectrom; 2006; 20(8):1351-60. PubMed ID: 16555373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrow-bore sample trapping and chromatography combined with quadrupole/time-of-flight mass spectrometry for ultra-sensitive identification of in vivo and in vitro metabolites.
    Foltz DJ; Castro-Perez J; Riley P; Entwisle JR; Baker TR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Oct; 825(2):144-51. PubMed ID: 16213447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatography/atmospheric pressure ionization-mass spectrometry in drug metabolism studies.
    Kostiainen R; Kotiaho T; Kuuranne T; Auriola S
    J Mass Spectrom; 2003 Apr; 38(4):357-72. PubMed ID: 12717747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional liquid chromatography/mass spectrometry set-up for structural elucidation of metabolites in complex biological matrices.
    Kiffe M; Graf D; Trunzer M
    Rapid Commun Mass Spectrom; 2007; 21(6):961-70. PubMed ID: 17299833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of recent innovations in the use of liquid chromatography-mass spectrometry in support of drug metabolism studies: are we all the way there yet?
    Nassar AE; Talaat RE; Kamel AM
    Curr Opin Drug Discov Devel; 2006 Jan; 9(1):61-74. PubMed ID: 16445118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical strategies for identifying drug metabolites.
    Prakash C; Shaffer CL; Nedderman A
    Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining.
    Triolo A; Altamura M; Dimoulas T; Guidi A; Lecci A; Tramontana M
    J Mass Spectrom; 2005 Dec; 40(12):1572-82. PubMed ID: 16320289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to hybrid ion trap/time-of-flight mass spectrometry coupled with liquid chromatography applied to drug metabolism studies.
    Liu ZY
    J Mass Spectrom; 2012 Dec; 47(12):1627-42. PubMed ID: 23280752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo investigation of metabolic fate of rifampicin using an optimized sample preparation approach and modern tools of liquid chromatography-mass spectrometry.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2009 Oct; 50(3):475-90. PubMed ID: 19535209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography-mass spectrometry (HPLC-MS)-based drug metabolite profiling.
    Wilson ID
    Methods Mol Biol; 2011; 708():173-90. PubMed ID: 21207290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of metabolism pathways of anticancer drugs by high-pressure liquid chromatography in combination with field desorption mass spectrometry.
    Przybylski M
    Arzneimittelforschung; 1982; 32(9):995-1012. PubMed ID: 6756419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of HILIC for targeted and non-targeted LC/MS analyses in drug discovery.
    Onorato JM; Langish R; Bellamine A; Shipkova P
    J Sep Sci; 2010 Mar; 33(6-7):923-9. PubMed ID: 20127913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
    Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
    J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.